What is IDEAYA Biosciences, Inc.'s revenue?

IDEAYA Biosciences, Inc. (IDYA) generated $232.3M in revenue over the trailing twelve months, up 5822.2% year over year.

Is IDEAYA Biosciences, Inc. profitable?

IDEAYA Biosciences, Inc. is not currently profitable: it reported a net loss of $140.1M over the trailing twelve months, a -3921.1% net margin.

What is IDEAYA Biosciences, Inc.'s earnings per share?

IDEAYA Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-1.60.

Where does IDEAYA Biosciences, Inc.'s income statement data come from?

Every line is extracted from IDEAYA Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

IDEAYA Biosciences, Inc. IDYA Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Total revenue	——	$7M-70.1%	$23.38M-54.1%	$50.93M+82.3%
Research and development	$314.7M+6.8%	$294.67M+128%	$129.51M+44.6%	$89.54M+54.0%
General and administrative	$63.32M+61.1%	$39.3M+38.8%	$28.31M+18.5%	$23.9M+19.2%
Other operating expenses	$378.02M+13.2%	$333.98M+112%	$157.82M+39.1%	$113.43M+45.0%
Total operating expenses	$378.02M+13.2%	$333.98M+112%	$157.82M+39.1%	$113.43M+45.0%
Operating income	-$159.31M+51.3%	-$326.98M-143%	-$134.43M-115%	-$62.5M-24.3%
Other income (expense), net	$45.62M-13.1%	$52.5M+145%	$21.47M+458%	$3.85M+660%
Net income	-$113.7M+58.6%	-$274.48M-143%	-$112.96M-92.6%	-$58.66M-17.9%
Diluted earnings per share	-$1.31+61.0%	-$3.36-70.6%	-$1.97-37.8%	-$1.43-1.4%
Basic earnings per share	-$1.29+61.6%	-$3.36-70.6%	-$1.97-37.8%	-$1.43-1.4%
Weighted-average shares, diluted	355M+10.6%	320.9M+44.5%	222.1M+39.0%	159.8M+16.1%
Weighted-average shares, basic	353.8M+10.3%	320.9M+44.5%	222.1M+39.7%	159M—
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	-$112.24M+59.1%	-$274.23M-150%	-$109.53M-80.1%	-$60.81M-20.5%
Net unrealized gains (losses) on securities still held	$1.46M—	——	$3.43M—	——
Revenue From Contract With Customer Excluding Assessed Tax	——	$7M-70.1%	$23.38M-54.1%	$50.93M+82.3%
EBIT	-$159.31M+51.3%	-$326.98M-143%	-$134.43M-115%	-$62.5M-24.3%
EBITDA	-$156.61M+51.8%	-$324.59M-146%	-$131.96M-118%	-$60.4M-24.4%
EBITDA	-$156.61M+51.8%	-$324.59M-146%	-$131.96M-118%	-$60.4M-24.4%
EBIT	-$159.31M+51.3%	-$326.98M-143%	-$134.43M-115%	-$62.5M-24.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about IDEAYA Biosciences, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is IDEAYA Biosciences, Inc.'s revenue?: IDEAYA Biosciences, Inc. (IDYA) generated $232.3M in revenue over the trailing twelve months, up 5822.2% year over year.
Is IDEAYA Biosciences, Inc. profitable?: IDEAYA Biosciences, Inc. is not currently profitable: it reported a net loss of $140.1M over the trailing twelve months, a -3921.1% net margin.
What is IDEAYA Biosciences, Inc.'s earnings per share?: IDEAYA Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-1.60.
Where does IDEAYA Biosciences, Inc.'s income statement data come from?: Every line is extracted from IDEAYA Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.